238 related articles for article (PubMed ID: 16707250)
1. The changing epidemiology of invasive fungal infections: new threats.
Maschmeyer G
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():3-6. PubMed ID: 16707250
[TBL] [Abstract][Full Text] [Related]
2. A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999.
Lortholary O; Charlemagne A; Bastides F; Chevalier P; Datry A; Gonzalves MF; Michel G; Tilleul P; Veber B; Herbrecht R
J Antimicrob Chemother; 2004 Aug; 54(2):456-64. PubMed ID: 15231769
[TBL] [Abstract][Full Text] [Related]
3. Overview of systemic fungal infections.
Rolston K
Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):11-4. PubMed ID: 11757845
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of opportunistic invasive mycoses.
Kullberg BJ; Oude Lashof AM
Eur J Med Res; 2002 May; 7(5):183-91. PubMed ID: 12069910
[TBL] [Abstract][Full Text] [Related]
5. [Fungal infections].
Kahanpää A
Duodecim; 1973; 89(23):1536-51. PubMed ID: 4589024
[No Abstract] [Full Text] [Related]
6. Fungal infections: correlation with previous treatment and use of antimycogram.
Grandis C; Balagna ME; Malandrino M; Marocco A
J Chemother; 1991 Jan; 3 Suppl 1():86-8. PubMed ID: 12041796
[TBL] [Abstract][Full Text] [Related]
7. An epidemic of invasive fungal infection in a stem cell transplant unit; response to high-dose liposomal amphotericin B.
Ryan C; McNicholsan S; O'Connell B; Forde S; Keoghan M; McCann SR
Hematol J; 2004; 5(6):548-51. PubMed ID: 15570304
[No Abstract] [Full Text] [Related]
8. Diagnosis of invasive fungal infections: advances in nonculture systems.
Walsh TJ; Chanock SJ
Curr Clin Top Infect Dis; 1998; 18():101-53. PubMed ID: 9779353
[No Abstract] [Full Text] [Related]
9. Prophylaxis of invasive mycoses in solid organ transplantation.
Alexander BD
Curr Opin Infect Dis; 2002 Dec; 15(6):583-9. PubMed ID: 12821834
[TBL] [Abstract][Full Text] [Related]
10. [Fungal maxillary sinusitis].
Grigoriu D; Bambule J; Delacrétaz J; Savary M
Dermatologica; 1979; 159(Suppl 1):180-6. PubMed ID: 385382
[TBL] [Abstract][Full Text] [Related]
11. The fungal profile of otomycosis patients in Ilorin, Nigeria.
Nwabuisi C; Ologe FE
Niger J Med; 2001; 10(3):124-6. PubMed ID: 11806011
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan.
Yamazaki T; Kume H; Murase S; Yamashita E; Arisawa M
J Clin Microbiol; 1999 Jun; 37(6):1732-8. PubMed ID: 10325316
[TBL] [Abstract][Full Text] [Related]
13. Invasive fungal infections in Kuwait: A retrospective study.
Khan ZU; Chugh TD
Indian J Chest Dis Allied Sci; 2000; 42(4):279-87. PubMed ID: 15597675
[TBL] [Abstract][Full Text] [Related]
14. Emerging fungal resistance.
Baddley JW; Moser SA
Clin Lab Med; 2004 Sep; 24(3):721-35, vii. PubMed ID: 15325062
[TBL] [Abstract][Full Text] [Related]
15. [Systemic mycoses. Epidemiology, clinical aspects, diagnosis].
Dobloug JH
Tidsskr Nor Laegeforen; 1992 Jun; 112(15):1940-4. PubMed ID: 1509451
[TBL] [Abstract][Full Text] [Related]
16. The changing epidemiology of fungal infections.
Lass-Flörl C; Steixner S
Mol Aspects Med; 2023 Dec; 94():101215. PubMed ID: 37804792
[TBL] [Abstract][Full Text] [Related]
17. [Candida, aspergillus and company. Pathogenic fungi].
Hof H
Pharm Unserer Zeit; 2003; 32(2):96-103. PubMed ID: 12677961
[No Abstract] [Full Text] [Related]
18. The epidemiology of candidaemia and mould infections in Australia.
Slavin MA;
J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():3-6. PubMed ID: 11801574
[TBL] [Abstract][Full Text] [Related]
19. Focus on risk factors for fungal infections in ICU patients.
Tufano R
Minerva Anestesiol; 2002 Apr; 68(4):269-72. PubMed ID: 12024098
[TBL] [Abstract][Full Text] [Related]
20. Antifungal drug resistance of pathogenic fungi.
Kontoyiannis DP; Lewis RE
Lancet; 2002 Mar; 359(9312):1135-44. PubMed ID: 11943280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
